European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 9:24

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 9:07

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 9:00

Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 8:57

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Date of authorisation: 30/10/2009, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 8:48

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Date of authorisation: 30/10/2009, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Date of authorisation: 14/08/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 6 May 2026 - 8:30

Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Date of authorisation: 14/08/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Integrilin, eptifibatide, Date of authorisation: 01/07/1999, Revision: 27, Status: Withdrawn

Submitted by Anonymous (not verified) on 6 May 2026 - 8:10

Human medicines European public assessment report (EPAR): Integrilin, eptifibatide, Date of authorisation: 01/07/1999, Revision: 27, Status: Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness